INMB
INmune Bio Inc. Common stock
BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Best Biotech Stocks 2026 →
INmune Bio (INMB) Stock: Buy, Sell, or Hold?
$1.05
-0.05 (-4.55%)
▼
5d:
-10.64%
30d:
-34.38%
90d:
-51.61%
QUANTITATIVE VERDICT
WAIT
LOW Confidence (77%)
Quality Score
46/100
Position
OVERSOLD
30-Day Fair Range
$1.40 – $1.87
Position: OVERSOLD
Forward P/E & Valuation
-2.4x
Next 12M consensus est.
Wall Street Target
$7.00
+566.7% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$1.01 / $1.56
Trend: Strong Downtrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
⏸️ WAIT FOR STABILIZATION: INMB is down 10.6% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
Get Alerted When INMB Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
In-depth Analysis How we analyze
Valuation Analysis: INMB is currently trading at $1.05, which is considered oversold relative to its 30-day fair value range of $1.40 to $1.87.
Technical Outlook: Technically, INMB is in a strong downtrend. Immediate support is located at $1.01, while resistance sits at $1.55. Short-term momentum is weak, with the stock down 4.5% recently.
Market Sentiment: The stock scores a mixed 45/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $7.00 (+566.7%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, INMB is in a strong downtrend. Immediate support is located at $1.01, while resistance sits at $1.55. Short-term momentum is weak, with the stock down 4.5% recently.
Market Sentiment: The stock scores a mixed 45/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $7.00 (+566.7%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$1.40 -
$1.87
Company Quality Score
46/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
77.4%
Trading Range & Key Levels
30-Day Trading Range
$1.40 -
$1.87
Current vs Trading Range
OVERSOLD
Support Level
$1.01
Resistance Level
$1.56
Current Trend
Strong Downtrend
Technical data as of
Nov 12, 2026
Quantitative Signal Breakdown
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (45/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-4.5%)
- BULLISH: Trading 566.7% below Wall St target ($7.00)
- WARNING: Composite score 46/100 in the bottom quintile — this cohort historically lags the market
Fundamental Context
Forward P/E (Next Year Est.)
-2.44
Wall Street Target
$7.00
(+566.7%)
Revenue Growth (YoY)
257.1%
Share INMB Analysis
Share this live INMB analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (INMB)
Bullish
2 Retail Mentions
Reddit / WSB Comments
1
Bullish
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Oct 20, 2026
Daily AI digest
AI Retail Discussion Summary:
One bullish StockTwits message suggests that selling of $INMB stock has been overdone and a new upward trend has begun.
Key Retail Themes:
Bullish sentiment
Price movement
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 12, 2026 8:07 PM ET
Data refreshes hourly during market hours. Next update: 9:07 PM
Data refreshes hourly during market hours. Next update: 9:07 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is INMB showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
IONS
Ionis Pharmaceuticals Inc |
STRONG BUY
25 analysts |
$84 | 45 HOLD |
|
ACLX
Arcellx Inc |
STRONG BUY
18 analysts |
$113 | 50 HOLD |
|
ABVX
Abivax SA American Depos… |
STRONG BUY
12 analysts |
$164 | 64 BUY |
|
STRO
Sutro Biopharma |
STRONG BUY
14 analysts |
$47 | 58 HOLD |
|
JANX
Janux Therapeutics Inc |
STRONG BUY
18 analysts |
$32 | 42 HOLD |
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive INMB Research Pages
